PL365672A1 - Processes for preparing cilostazol - Google Patents

Processes for preparing cilostazol

Info

Publication number
PL365672A1
PL365672A1 PL01365672A PL36567201A PL365672A1 PL 365672 A1 PL365672 A1 PL 365672A1 PL 01365672 A PL01365672 A PL 01365672A PL 36567201 A PL36567201 A PL 36567201A PL 365672 A1 PL365672 A1 PL 365672A1
Authority
PL
Poland
Prior art keywords
processes
preparing cilostazol
cilostazol
preparing
Prior art date
Application number
PL01365672A
Other languages
Polish (pl)
Inventor
Marioara Mendelovichi
Nina Finkelstein
Gideon Pilarksi
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of PL365672A1 publication Critical patent/PL365672A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
PL01365672A 2000-08-14 2001-08-14 Processes for preparing cilostazol PL365672A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22536200P 2000-08-14 2000-08-14

Publications (1)

Publication Number Publication Date
PL365672A1 true PL365672A1 (en) 2005-01-10

Family

ID=22844569

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01365672A PL365672A1 (en) 2000-08-14 2001-08-14 Processes for preparing cilostazol

Country Status (17)

Country Link
EP (1) EP1311485A4 (en)
JP (2) JP3845059B2 (en)
KR (1) KR20030024865A (en)
CN (1) CN1469864A (en)
AU (1) AU2001284887A1 (en)
CA (1) CA2419181A1 (en)
CZ (1) CZ2003667A3 (en)
HK (1) HK1053116A1 (en)
HU (1) HUP0302688A2 (en)
IL (1) IL154458A0 (en)
IS (1) IS6716A (en)
MX (1) MXPA03001470A (en)
NO (1) NO20030699L (en)
NZ (1) NZ524363A (en)
PL (1) PL365672A1 (en)
SK (1) SK2992003A3 (en)
WO (1) WO2002014283A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045547A1 (en) 2001-05-02 2003-03-06 Shinji Aki Process for producing carbostyril derivatives
US7399864B2 (en) 2001-05-02 2008-07-15 Otsuka Pharmaceutical Co., Ltd. Process for producing carbostyril derivatives
US20050101631A1 (en) 2002-08-01 2005-05-12 Otsuka Pharmaceuticals Company Process for producing carbostyril derivatives
PT1489080E (en) * 2002-09-10 2011-02-16 Otsuka Pharma Co Ltd Process for producing cilostazol
JP2007523068A (en) 2004-02-05 2007-08-16 テバ ファーマシューティカル インダストリーズ リミティド Method for producing 7- (4-bromobutoxy) -3,4-dihydrocarbostyril
KR100633232B1 (en) * 2004-08-25 2006-10-11 주식회사유한양행 A novel method for purification of 6-[4-1-cyclohexyl-1h-tetrazol-5-ylbutoxy-3,4-dihydro-21h-quinolinone having high purity
WO2007124025A2 (en) * 2006-04-20 2007-11-01 Teva Pharmaceutical Industries Ltd. Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone
TW200848041A (en) 2007-03-30 2008-12-16 Otsuka Pharma Co Ltd A medicament for treating schizophrenia comprising cilostazol
EP2527336A1 (en) 2007-04-25 2012-11-28 Concert Pharmaceuticals Inc. Deuterated analogues of cilostazol
CN101434598B (en) * 2008-12-19 2012-11-07 重庆康乐制药有限公司 Preparation of cilostazol
CN102086190B (en) * 2011-01-28 2013-07-10 海南美兰史克制药有限公司 Cilostazol compound and novel preparation method thereof
CN107382970A (en) * 2017-07-26 2017-11-24 浙江金立源药业有限公司 A kind of synthetic method of Cilostazol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5535019A (en) * 1978-09-01 1980-03-11 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
JPH01265051A (en) * 1988-04-14 1989-10-23 Fuji Photo Film Co Ltd Production of diaryloxyalkane

Also Published As

Publication number Publication date
AU2001284887A1 (en) 2002-02-25
IL154458A0 (en) 2003-09-17
NZ524363A (en) 2004-03-26
WO2002014283A1 (en) 2002-02-21
CZ2003667A3 (en) 2003-08-13
IS6716A (en) 2003-02-13
NO20030699L (en) 2003-04-10
HUP0302688A2 (en) 2003-12-29
HK1053116A1 (en) 2003-10-10
JP2005350474A (en) 2005-12-22
MXPA03001470A (en) 2005-06-30
NO20030699D0 (en) 2003-02-13
JP3845059B2 (en) 2006-11-15
EP1311485A1 (en) 2003-05-21
SK2992003A3 (en) 2003-10-07
JP2004506043A (en) 2004-02-26
EP1311485A4 (en) 2004-05-12
CN1469864A (en) 2004-01-21
KR20030024865A (en) 2003-03-26
CA2419181A1 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
EG23914A (en) Process for preparing an antichnolinergic
EG23951A (en) Cilostazol preparation
GB0011120D0 (en) Process
HUP0300160A3 (en) Process for preparing (+)-cis-sertraline
GB0013793D0 (en) Process
IL154458A0 (en) Processes for preparing cilostazol
GB0010437D0 (en) Process
HUP0104405A2 (en) Process for preparing imidachlopid
HUP0300241A3 (en) Processes for preparing torsemide intermediate
HUP0300114A3 (en) Process for preparing flavonoid-derivatives
HUP0301649A3 (en) Process for preparing azacycloalkanoylaminothiazoles
HUP0201837A3 (en) Process for preparation n-carboxy-anhydrides
GB0002201D0 (en) Process
GB0020021D0 (en) Process
GB0014583D0 (en) Process
GB0013791D0 (en) Process
GB0016633D0 (en) Process
HUP0204443A3 (en) Process for preparing fluoroformates
GB0006722D0 (en) Process
GB0001564D0 (en) Process
HU0000377V0 (en) Toy-set for construction-modelling
HU0104169D0 (en) Process for plain-vine-stock wine-planting
AU2287902A (en) New process for the preparation diaryl-4-amino-piperidinyl compounds
GB0000935D0 (en) Process
GB0006837D0 (en) Process